Reported about 20 hours ago
Camilla Sylvest, the head of commercial strategy and corporate affairs at Novo Nordisk, has announced her resignation. Ludovic Helfgott, currently leading the rare disease unit, will take over her responsibilities, overseeing product strategy, medical affairs, and business development. Sylvest was one of only two women on the company's executive management team, and her departure comes as Novo asserts its commitment to diversity and inclusion amidst changing sentiments in the pharmaceutical sector.
Source: YAHOO